Riehen, Switzerland

Katharina Reichenbaecher

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katharina Reichenbaecher. Retrieved from https://idiyas.com/inventor/katharina-reichenbaecher-a64uv0se

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katharina Reichenbaecher: Innovator in Pharmaceutical Chemistry

Introduction

Katharina Reichenbaecher is a notable inventor based in Riehen, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Reichenbaecher holds a patent for "Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester." This invention relates to crystalline salts of isobutyric acid and their use as medicaments, especially as calcium channel blockers. The patent highlights processes for the preparation of these salts and pharmaceutical compositions containing them.

Career Highlights

Katharina Reichenbaecher is associated with Actelion Pharmaceuticals Ltd., where she has been instrumental in advancing research and development in the pharmaceutical sector. Her work has contributed to the creation of innovative therapeutic solutions.

Collaborations

Reichenbaecher has collaborated with esteemed colleagues such as Stéphanie Combes and Francis Hubler, enhancing the collaborative spirit within her research environment.

Conclusion

Katharina Reichenbaecher's contributions to pharmaceutical chemistry and her innovative patents underscore her role as a leading inventor in her field. Her work continues to impact the development of new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…